Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > NOT IN KANSAS
View:
Post by skyhawk1 on May 25, 2022 9:20am

NOT IN KANSAS

Very well said. This is a very unique & special play! Many of us SUPER LONGS know what we have here!


We have been very supportive & very patient for many years bcuz to many of us this is a family MISSION of sorts, to say the least?!


I know it can hard to watch at times but don't get lured or suckered into the TLT stockhouse chat room 'SEWER RAT'  boiler room antics & purposely created & induced 'sell-offs' on very small volume?!
 

These periodic sell-offs on very low volume tell u everything u need to know. GO BIG $$ OR GO HOME!!
 

Most of us very signifacant 'buy & hold' stakeholders would rather continue to buy the selective DIPS instead, when they become available?!


Bcuz our immense holdings would CRASH the stock much more so otherwise, if we try to play the 'sewer rat' sell games for FLIPPIN' PENNIES & all the great potential & momentum would STALL going forward!!


However, many of you need to turn off the key boards/pads etc & go out & enjoy the summer outdoors & nature's bounty?! You will stay young & live longer!!


You need to RELAX & patiently wait for the end game to DEVELOP soon enough?!


REMEMBER FOLLOW DR. SHERRIE'S SCIENCE ~ THE NEW HIRES ~ THE SCIENCE SPECIALISTS & EXPERTS & THE "WHITE'S FAMILY MONEY" IN MY OPINION!


Now back to our regularly scheduled PLAYIN' & CRUISIN' lifestyle folks! LOL


G'day super longs & great PATRIOTS!

Comment by Rumpl3StiltSkin on May 25, 2022 10:28am
Well said S&B and Skyhawk, It is likely just a couple hundred of us Longs that have stuck with TLT thus far. We all want to see how this plays out. I doubt any of us are willing to sell cheap. TLT management has just shown us what they think by exercising warrants. :-)
Comment by Legit62 on May 25, 2022 10:49am
Im with you guys, long well over a million shares, not selling below $10, by the way , ETrade wouldnt accept my transfer of TLT from Vanguard as they said they would, you can trade TLT on Etrade but wouldnt accept transfer, im not selling anyways and i also have a td Ameritrade acct with over 100,000 shares that i can still trade, so be it, staying long and we are getting very close or maybe deal ...more  
Comment by ScienceFirst on May 25, 2022 11:18am
Legit62 ... 10$US/share would give TLT a market valuation of 2B$US for 204M share (TSO), which is in the valuation bracket of oncology drugs that are seen as growing candidates whether for a takeover or ones that are seen as jv candidates.   In our case, given that we instantly destroy without any assistance, with no toxicity, with only 2 treatments, we could be valued a bit higher just for ...more  
Comment by 99942Apophis on May 25, 2022 2:25pm
ScienceFirst wrote  Legit62 ... 10$US/share would give TLT a market valuation of 2B$US for 204M share (TSO), which is in the valuation bracket of oncology drugs that are seen as growing candidates whether for a takeover or ones that are seen as jv candidates.   In our case, given that we instantly destroy without any assistance, with no toxicity, with only 2 treatments, we could be ...more  
Comment by ScienceFirst on May 25, 2022 2:50pm
99942Apophis ... When you look at the market valuation of any stocks (biotech or not) via a quote inquiry, that valuation is always based on non-fully diluted shares (TSO), as the non-fully diluted share numbers are not available.  So I use the same basis of comparison. Takeover valuations on their part do consider fully diluted shares. _____________________________ 99942Apophis ...more  
Comment by ScienceFirst on May 25, 2022 2:53pm
99942Apophis ... When you look at the market valuation of any stocks (biotech or not) via a quote inquiry, that valuation is always based on non-fully diluted shares (TSO), as the fully diluted share numbers are not available.  So I use the same basis of comparison. Takeover valuations on their part do consider fully diluted shares. _____________________________ 99942Apophis ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250